S. 526 · 118th Congress (2023–2025)
BENEFIT Act of 2023
This bill requires the Food and Drug Administration (FDA) to consider relevant patient experience data in the risk-benefit assessment framework used in the process for approving new drugs.
After a new drug application has been approved, the FDA's public statement about how it used patient experience data shall include a description of how such data was considered in the risk-benefit assessment framework.
Show official title
A bill to strengthen the use of patient-experience data within the benefit-risk framework for approval of new drugs.
Expired in Senate committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to committee
This bill’s path
This is S. 526’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed Senate
Passed House
Sent to President
Signed into law
Expired
- Sponsor
- Sen. Roger F. Wicker (R-MS)
- Cosponsors
5 cosponsors
1 original · 4 later
- Sen. Amy Klobuchar (D-MN)· Original · Feb 16, 2023
- Sen. Susan M. Collins (R-ME)· Later · Mar 8, 2023
- Sen. Mike Braun (R-IN)· Later · Mar 28, 2023
- Sen. Rick Scott (R-FL)· Later · Oct 17, 2023
- Sen. Bill Hagerty (R-TN)· Later · Apr 30, 2024
- Policy area
- Health
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in Senate
Document: Introduced in Senate
Sources
- Congress.gov action
- Library of Congress
- Latest
Referred to committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sources
- Congress.gov action
- Senate
Expired
Introduced → Referred to Senate Health, Education, Labor, and Pensions → No further action before the 118th Congress ended.
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in Senate |
Titles (3)
BENEFIT Act of 2023
Display title, Short title · Introduced in Senate
Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023
Short title · Introduced in Senate
A bill to strengthen the use of patient-experience data within the benefit-risk framework for approval of new drugs.
Official title · Introduced in Senate